What is the purpose of this trial?
The purpose of this study is to assess the efficacy of intravenous brivaracetam (BRV) compared to intravenous lorazepam (LZP) in subjects with epilepsy undergoing Epilepsy Monitoring Unit (EMU) evaluation who experience seizures that require prompt treatment.
Ages: 18 - 70 years
Dates: 10/23/2017 - 06/30/2018
Last Updated: 10/24/2017
Study HIC#: 2000021003